• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
The effect of the opioid crisis on babies

The effect of the opioid crisis on babies

by Truveta Research | Apr 30, 2023 | Research, Research Insights

Since the 1990s, the negative impact of prescription opioids – particularly death from overdose – have become an epidemic in the US (Centers for Disease Control and Prevention, 2022; Paulozzi et al., 2011). More recently, in the early 2010s, the US embarked on a new...
Huddle up: Injury comparisons across sports

Huddle up: Injury comparisons across sports

by Truveta Research | Apr 27, 2023 | Research, Research Insights

While many adults engage in sports, even more children participate in sports (Blendon et al., 2015). A 2020 report suggests that over 50% of children between 6-17 have participated in sports within the last year (Black et al., 2022), which is an increase from under...
Double play: Multi-injury athletes, by the numbers

Double play: Multi-injury athletes, by the numbers

by Truveta Research | Apr 21, 2023 | Research, Research Insights

With over 3.5 million sport injuries estimated to occur each year (Johns Hopkins Medicine, 2023), we spent the last several weeks digging into and describing injury patterns related to specific sports: basketball, soccer, baseball/softball, and football. Although...
How does approval of a new Alzheimer’s drug impact genetic testing?

How does approval of a new Alzheimer’s drug impact genetic testing?

by Truveta Research | Apr 21, 2023 | Research, Research Insights

The National Institute of Health estimates that more than six million Americans over the age of 65 suffer from Alzheimer’s disease, with many more under the age of 65 also having the disease (National Institute on Aging, 2021). It is currently ranked as the seventh...
Revolutionizing patient care with AI in healthcare: How Truveta leverages data and AI to make a difference

Revolutionizing patient care with AI in healthcare: How Truveta leverages data and AI to make a difference

by Truveta staff | Apr 20, 2023 | Technology

Truveta is a healthcare company that is passionate about improving patient care and saving lives by harnessing the transformative potential of EHR data and artificial intelligence (AI). In a recent article from Microsoft that highlighted our vision and mission, “How...
« Older Entries

Share this


Recent posts

  • Real-world survival outcomes for CRT and CCM therapies align with landmark trials
  • Understanding the potential impact of the upcoming ACIP vote on thimerosal-containing influenza vaccines
  • Biosimilar use is on the rise – but 1 in 8 patients return to Humira

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice